Advertisement

Loading...

3SBio Inc.

1530.HKHKSE
Healthcare
Biotechnology
HK$25.26
HK$2.62(11.57%)
Hong Kong Market is Open • 11:48

3SBio Inc. Fundamental Analysis

3SBio Inc. (1530.HK) shows strong financial fundamentals with a PE ratio of 22.82, profit margin of 25.99%, and ROE of 14.85%. The company generates $8.8B in annual revenue with strong year-over-year growth of 16.53%.

Key Strengths

Operating Margin26.36%
Current Ratio2.34

Areas of Concern

No major concerns flagged.
We analyze 1530.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 76.3/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
76.3/100

We analyze 1530.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

1530.HK struggles to generate sufficient returns from assets.

ROA > 10%
9.90%

Valuation Score

Excellent

1530.HK trades at attractive valuation levels.

PE < 25
22.82
PEG Ratio < 2
1.87

Growth Score

Excellent

1530.HK delivers strong and consistent growth momentum.

Revenue Growth > 5%
16.53%
EPS Growth > 10%
40.98%

Financial Health Score

Excellent

1530.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.11
Current Ratio > 1
2.34

Profitability Score

Moderate

1530.HK maintains healthy but balanced margins.

ROE > 15%
14.85%
Net Margin ≥ 15%
25.99%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 1530.HK Expensive or Cheap?

P/E Ratio

1530.HK trades at 22.82 times earnings. This indicates a fair valuation.

22.82

PEG Ratio

When adjusting for growth, 1530.HK's PEG of 1.87 indicates fair valuation.

1.87

Price to Book

The market values 3SBio Inc. at 3.30 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.30

EV/EBITDA

Enterprise value stands at 19.41 times EBITDA. This signals the market has high growth expectations.

19.41

How Well Does 1530.HK Make Money?

Net Profit Margin

For every $100 in sales, 3SBio Inc. keeps $25.99 as profit after all expenses.

25.99%

Operating Margin

Core operations generate 26.36 in profit for every $100 in revenue, before interest and taxes.

26.36%

ROE

Management delivers $14.85 in profit for every $100 of shareholder equity.

14.85%

ROA

3SBio Inc. generates $9.90 in profit for every $100 in assets, demonstrating efficient asset deployment.

9.90%

Following the Money - Real Cash Generation

Operating Cash Flow

3SBio Inc. produces operating cash flow of $2.05B, showing steady but balanced cash generation.

$2.05B

Free Cash Flow

3SBio Inc. generates strong free cash flow of $1.62B, providing ample flexibility for dividends, buybacks, or growth.

$1.62B

FCF Per Share

Each share generates $0.69 in free cash annually.

$0.69

FCF Yield

1530.HK converts 3.19% of its market value into free cash.

3.19%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

22.82

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.87

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.77

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.34

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.15

vs 25 benchmark

ROA

Return on assets percentage

0.10

vs 25 benchmark

ROCE

Return on capital employed

0.12

vs 25 benchmark

How 1530.HK Stacks Against Its Sector Peers

Metric1530.HK ValueSector AveragePerformance
P/E Ratio22.8228.31 Better (Cheaper)
ROE14.85%699.00% Weak
Net Margin25.99%-130884.00% (disorted) Strong
Debt/Equity0.110.34 Strong (Low Leverage)
Current Ratio2.342775.16 Strong Liquidity
ROA9.90%-14469.00% (disorted) Weak

1530.HK outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 3SBio Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

76.57%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

121.33%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

74.87%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ